Gentamicin for the practicing urologist: Review of efficacy, single daily dosing and "switch" therapy

Citation
Ra. Santucci et Jn. Krieger, Gentamicin for the practicing urologist: Review of efficacy, single daily dosing and "switch" therapy, J UROL, 163(4), 2000, pp. 1076-1084
Citations number
150
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF UROLOGY
ISSN journal
00225347 → ACNP
Volume
163
Issue
4
Year of publication
2000
Pages
1076 - 1084
Database
ISI
SICI code
0022-5347(200004)163:4<1076:GFTPUR>2.0.ZU;2-#
Abstract
Purpose: We review the literature on gentamicin, including single daily dos ing and "switch" therapy. Materials and Methods: We used MEDLINE to search the literature from 1966 t o June 1997, and then manually searched bibliographies to identify studies that our initial search might have missed. Results: Gentamicin has attractive characteristics, including wide spectrum , infrequent resistance, economy and familiarity. Although limited by well known toxicities, gentamicin remains a drug of choice for serious Gram-nega tive infections. Dosing strategies, such as single daily dosing and switch therapy, have renewed enthusiasm for this time-honored drug. Conclusions: Gentamicin remains a valuable drug in urology. Once daily dosi ng and switch therapy offer the potential to increase effectiveness and con venience while decreasing toxicity and costs.